key: cord-0933489-d5v0svoy authors: Manzur‐Sandoval, Daniel; García‐Cruz, Edgar; Gopar‐Nieto, Rodrigo; Arteaga‐Cárdenas, Gerardo; Rascón‐Sabido, Rafael; Mendoza‐Copa, Gastón; Lazcano‐Díaz, Emmanuel; Barajas‐Campos, Ricardo Leopoldo; Jordán‐Ríos, Antonio; Rodríguez‐Jiménez, Gian Manuel; Martínez, Daniel Sierra‐Lara; Murillo‐Ochoa, Adriana Lizeth; Díaz‐Méndez, Arturo; Bucio‐Reta, Eduardo; Rojas‐Velasco, Gustavo; Baranda‐Tovar, Francisco title: Right ventricular dysfunction and right ventricular–arterial uncoupling at admission increase the in‐hospital mortality in patients with COVID‐19 disease date: 2021-07-19 journal: Echocardiography DOI: 10.1111/echo.15164 sha: 40190d3169db017c1b4510bd5449b03520d89fe6 doc_id: 933489 cord_uid: d5v0svoy BACKGROUND: Coronavirus disease 2019 (COVID‐19) frequently involves cardiovascular manifestations such as right ventricular (RV) dysfunction and alterations in pulmonary hemodynamics. We evaluated the application of the critical care ultrasonography ORACLE protocol to identify the most frequent alterations and their influence on adverse outcomes, especially those involving the RV (dilatation and dysfunction). METHODS: This cross‐sectional study included 204 adult patients with confirmed COVID‐19 admitted at three centers. Echocardiography and lung ultrasound images were acquired on admission using the ORACLE ultrasonography algorithm. RESULTS: Two‐hundred and four consecutive patients were evaluated: 22 (11.9%) demonstrated a fractional shortening of < 35%; 33 (17.1%) a tricuspid annular plane systolic excursion (TAPSE) of < 17 mm; 26 (13.5%) a tricuspid peak systolic S wave tissue Doppler velocity of < 9.5 cm/sec; 69 (37.5%) a RV basal diameter of > 41 mm; 119 (58.3%) a pulmonary artery systolic pressure (PASP) of > 35 mm Hg; and 14 (11%) a TAPSE/PASP ratio of < .31. The in‐hospital mortality rate was 37.6% (n = 71). Multiple logistic regression modeling showed that PASP > 35 mm Hg, RV FS of < 35%, TAPSE < 17 mm, RV S wave < 9.5, and TAPSE/PASP ratio < .31 mm/mm Hg were associated with this outcome. PASP and the TAPSE/PASP ratio had the lowest feasibility of being obtained among the investigators (62.2%). CONCLUSION: The presence of RV dysfunction, pulmonary hypertension, and alteration of the RV–arterial coupling conveys an increased risk of in‐hospital mortality in patients presenting with COVID‐19 upon admission; therefore, searching for these alterations should be routine. These parameters can be obtained quickly and safely with the ORACLE protocol. The development of heart failure in patients with COVID-19 is not only a consequence of left ventricular (LV) dysfunction, but also right ventricular (RV) dysfunction, with an estimated frequency of 28%-39%. 4, 5 The mechanism of RV dysfunction is multifactorial, including microvascular thrombi in the pulmonary vessels and pulmonary vasoconstriction produced by hypoxemia and hypercapnia, all producing an increase in RV afterload. 6, 7 Severe COVID-19 disease usually requires invasive mechanical ventilation with high ventilatory parameters. This high transpulmonary pressure can lead to alveolar overdistension that causes compression of the alveolar capillaries, resulting in an increased pulmonary vascular resistance, which contributes to the RV dysfunction. 8, 9 García-Cruz et al. reported an increased pulmonary artery systolic pressure (PASP) in up to 69.5% of patients. 4 Ventricular-arterial coupling involves the relationship between contractility and afterload, which can be evaluated with echocardiography by the tricuspid annular plane systolic excursion (TAPSE)/PASP ratio. Patients with a TAPSE/PASP ratio of < .31 mm/mm Hg had a significantly worse prognosis in cases of severe pulmonary hypertension. 10 The critical care ultrasonography algorithm-the ORACLE protocolallows the evaluation of LV and RV function, valves, pericardial effusion, diastolic function and filling pressures, pulmonary hemodynamics, regional wall motion, and stratification of the severity of pulmonary affection, to obtain greater prognostic certainty and thereby determine the most appropriate treatment. 4 The objective of our research was to evaluate the application of a critical care ultrasound protocol in patients admitted to three intensive care units with SARS-CoV-2 infec-tion leading to COVID-19 to identify the most frequent alterations and their influence with adverse outcomes, especially those involving the RV (dilatation and dysfunction) and RV-arterial coupling. Clinical data were collected from 204 consecutive patients with confirmed SARS-CoV-2 infection and COVID-19 disease. Most of the patients were men (59.3%), with a median age of 59 (range 48-67) years, and the most frequent comorbidities were hypertension From all the echocardiographic measurements, PASP and TAPSE/PASP had the lowest feasibility (62.2%), whereas the other parameters had more than 80% feasibility among operators. RV S wave and TAPSE were the most commonly feasible measurements among operators at 94.6% and 94.1%, respectively (Appendix Table 1 ). The median fractional shortening (FS), TAPSE, S wave, RV basal diameter, PASP and TAPSE/PASP ratio were within normal ranges, independent of PaO 2 /FiO 2 values ( The (Tables 3 and 4 ). The median LV diastolic diameter (LVDD), LV outflow tract, velocitytime index, cardiac output, LV ejection fraction (LVEF), and mitral annular plane systolic excursion (MAPSE) were within normal ranges, independent of the PaO 2 /FiO 2 value ( Twenty-three patients (12.6%) had valvular heart disease: eight with mild mitral regurgitation; 12 with mild tricuspid regurgitation; three with moderate aortic regurgitation; one with moderate tricuspid regur-gitation; one with prosthetic mitral valve dysfunction; and one with moderate aortic stenosis. Sixteen patients (8.4%) had pericardial effusion (Table 3) . Two patients had a final diagnosis of cardiac tamponade. An average LUS score of 17 points was documented ( Considering diastolic function, the median of the E/e′ ratio was 8. Pulmonary embolism was diagnosed in 17 patients, cardiac tamponade in two, and Takotsubo syndrome, pneumothorax, right atrium thrombus, ventricular septal defect, pleural effusion, apical aneurysm, and a left atrium thrombus each were found in one patient. Table 1) . Among the clinical variables, a PaO 2 / FiO 2 < 100 (OR 11.1, p = 0.00) and a Ddimer > 500 mg/dl (OR 3.75, p = 0.00) also were associated with inhospital death. Our study highlights not only the elevated rate of dysfunction and dilation of the RV (although less than previously reported) and the alterations in pulmonary hemodynamics, but also the impact on mortality when detected at hospital admission. Routine critical care Abbreviations: RV, right ventricular; FS, fractional shortening; TAPSE, tricuspid annular plane systolic excursion; S wave, peak systolic tissue velocity at the tricuspid annulus; PASP, pulmonary artery systolic pressure; IVC, inferior vena cava; NT-proBNP, N-terminal B-type natriuretic peptide. ultrasonographic evaluation is essential given the high frequency of CV manifestations in patients presenting with COVID-19 disease. Given the high frequency of refractory hypoxemia using prone position ventilation, these evaluations have been also described during this maneuver. 12, 13 Critical care ultrasonography should be focused to maximize the time at the patient's bedside to limit exposure to airborne SARS-CoV-2 shedding to protect the staff caring for the patient. One of the main conditions that determine the high morbidity and mortality in patients with severe COVID-19 is myocardial involvement and the risk of developing RV dysfunction along with pulmonary hypertension. 14 The frequency of RV dysfunction and dilation was greater than 10% at hospital admission among these patients, and the elevation of PASP was close to 60%. RV alterations were not closely linked to was present in close to 20% of the patients with a pericardial effusion close to 10%. This was probably related to the myocardial and pericardial inflammatory involvement already described in patients with COVID 19. 20, 21 Elevation of the LV filling pressures (E/e′ > 14) was found in approximately 20% of patients. This could be linked with LV dysfunction or with the fluid overload following the initial aggressive fluid resuscitation usually required in these patients associated with severe sepsis or septic shock status at the hospital admission in this population. 22 Finally, the ORACLE protocol orientated not only the hemodynamic profile and guided resuscitation in the patients, but also established the final diagnosis of a specific CV entity in 24 patients with the most common diagnosis being a pulmonary embolism. The cross-sectional nature of our study precluded the possibility of ascertaining causal relationships but provided some rationale to establish questions about the pathophysiology of COVID-19. Furthermore, our research was conducted at three medical centers. Thus, this protocol should be replicated at other centers to assess its reproducibility. In addition, the parameters that showed higher mortality were more difficult to quantify than the rest of the echocardiographic variables. The presence of RV dysfunction, elevated PASP, and a poor RV-arterial coupling at hospital admission in patients with COVID-19 disease conferred a higher risk for in-hospital mortality. Therefore, these conditions should be searched for in a targeted manner to identify those at higher risk, especially in patients with a higher degree of hypoxemia. The ORACLE protocol can help to obtain these parameters quickly and safely at the bedside and is also a tool that-given its ease and versatility-allows most of the echocardiographic parameters to be acquired. Cardiac involvement of COVID-19: a comprehensive review Covid-19 and the cardiovascular system: a comprehensive review COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives Critical care ultrasonography during COVID-19 pandemic: the ORA-CLE protocol Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study The right ventricle in COVID-19 lung injury: proposed mechanisms, management, and research gaps Anatomy, function, and dysfunction of the right ventricle: JACC state-of-the-art review The relationship between the right ventricle and its load in pulmonary hypertension Acute right ventricular failure in COVID-19 infection: a case series Validation of the tricuspid annular plane systolic excursion /systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension The ARDS definition task force*. Acute respiratory distress syndrome: the berlin definition Transthoracic echocardiography during prone position ventilation: lessons from the COVID-19 pandemic Man with dyspnea, dry cough and fever Impact of right ventricular dysfunction on mortality in patients hospitalized with COVID-19, according to race The role of hypercapnia in acute respiratory failure Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS San Matteo COVID cardiac injury task force. Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy Association between fluid intake and mortality in critically ill patients with negative fluid balance: a retrospective cohort study Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 COVID-19 and myocarditis: what do we know so far Cardiac tamponade in a patient with myocardial infarction and COVID-19: electron microscopy Viral sepsis is a complication in patients with Novel Corona Virus Disease (COVID-19) Right ventricular dysfunction and right ventricular-arterial uncoupling at admission increase the in-hospital mortality in patients with COVID-19 disease We thank the INC Critical Care Ultrasonography Working Group. The authors declare that there are no conflicts of interest to disclose.